Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03027518 · ClinicalTrials.gov registry record · NA

WILD 5 Wellness: A 30-Day Intervention

A NA study, sponsored by Beloit College.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT03027518: Completed NA study, sponsored by Beloit College.

NCT03027518 is a NA study that has completed, run by Beloit College. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03027518, a NA study, has completed, sponsored by Beloit College.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in Beloit College students. This program is called "WILD 5 Wellness: A 30-Day Intervention". Results for this study will be quantified through the use of standardized self-report questionnaires administered prior to and after students complete the WILD 5 program (Group 1) or 30 days of inactive participation (Group 2), and again approximately 30 days later when the initially inactive group (Group 2) will have just completed their active participation in the WILD 5 program and the first WILD 5 group (Group 1) will be approximately 30 days out from completion of their WILD 5 active portion. Data will be collected to evaluate participants' adherence and response to each element of WILD 5, a 5-pronged 30-day wellness intervention. It is expected that this 30-day integrated, prescriptive, and trackable program will be found to be an efficacious wellness intervention for Beloit College students as compared to the control (inactive) group of students not participating in the Active program.

Interventions

  • OTHER WILD 5 Wellness

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2017-02-06
Est. Completion 2017-12-05
Phase NA
Beloit College

3 total trials

What the finished NCT03027518 record still lists

NCT03027518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which WILD 5 Wellness is the first listed.

NCT03027518 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03027518 about?

NCT03027518 is a clinical study titled "WILD 5 Wellness: A 30-Day Intervention". The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in Beloit College students. This program is called "WI...

What is the current status of trial NCT03027518?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2017-02-06. Estimated completion is 2017-12-05.

What interventions are being tested in trial NCT03027518?

The interventions under investigation include: WILD 5 Wellness (OTHER).

Who is sponsoring clinical trial NCT03027518?

This trial is sponsored by Beloit College, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03027518's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03027518, the US trial registry maintained by the National Library of Medicine. NCT03027518 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.